TrialBritish journal of cancer2006

SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer.

P A Vasey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.